Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
Sanofi named Connect & Coach as the winner of its 2013 Data Design Diabetes contest
Pharmas need to start fine-tuning paid search and producing "liquid content" that moves fluidly between screens, said Google's David Blair at our first MM&M Skill Sets Live session
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.